SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001657312-23-000015
Filing Date
2023-08-03
Accepted
2023-08-03 06:11:51
Documents
14
Period of Report
2023-08-03
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K vrna-20230803.htm   iXBRL 8-K 39785
2 EX-99.1 vrnaq22023pressrelease.htm EX-99.1 55704
6 GRAPHIC verona_pharmaxnewxflushxfua.jpg GRAPHIC 139524
  Complete submission text file 0001657312-23-000015.txt   412295

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20230803.xsd EX-101.SCH 1904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20230803_lab.xml EX-101.LAB 24635
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20230803_pre.xml EX-101.PRE 12988
8 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20230803_htm.xml XML 2783
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 231137882
SIC: 2834 Pharmaceutical Preparations